PalanerFree on the App Store
Get
PalanerFinds what's on in Boston
Sign in

ITA 7th Edition Life Sciences Acceleration | Matchmaking Sprint 5 with Pharma CVC & Partners by Elpis Labs
WorkFree

ITA 7th Edition Life Sciences Acceleration | Matchmaking Sprint 5 with Pharma CVC & Partners by Elpis Labs

Tuesday 10 November 2026, 16:30

Venue time (New York)

Tuesday 10 November 2026, 16:30Venue time (New York)
FreeTickets sold by luma.com
Book · Freevia luma.com
Add to calendar

Downloads an .ics file · Times are in America/New_York · Google Calendar

Hey, how's it going? ITA 7th Edition Life Sciences Acceleration looks like it should be pretty interesting. Want me to help you organise around it?

Event details

Tickets sold by luma.com

Add to calendar · Downloads an .ics file · Times are in America/New_York · Google Calendar

The East Coast round: ten Italian life sciences companies, in Kendall Square, in dedicated 1:1s.

The final matching sprint of the ITA Life Sciences Accelerator, and the only one on the East Coast.

After three weeks in San Diego working through entity structuring, FDA pathways, payer systems and West Coast capital, the cohort moves to Boston for its closing week — CGMP compliance, Kendall Square institutional networks, Longwood clinical briefings.

These meetings are where corporate venture and pharma partnership conversations get started, two days before the final demo day.

WHY TAKE THESE MEETINGS

Differentiated European deal flow, pre-screened by the Italian Trade Agency

Assets aligned to U.S. regulatory and CGMP expectations before the conversation starts

Seed to Series A/B across MedTech, Biotech, Pharma and Digital Health

Founders with a committed U.S. presence and an Elpis Labs team behind the follow-through

The Boston Demo Day follows on Nov 12 — meet privately first, then see them pitch

THE COHORT — 10 ITALIAN COMPANIES, SEED TO SERIES A/B

Biotech & Pharma:— Kiran Biotech (AvidinOX® platform delivering radiotherapeutics directly to inoperable tumors) — THERA65 (aptamer-based PROTAC degrading p65BTK to break drug resistance in solid tumors) — BrightMol Biotech (Univ. of Trento spin-off; LIPS fluorescent target validation, 4× faster and 50% cheaper)

Digital Health & MedTech:— Nemira (privacy-first ambient AI monitoring for older adults with memory disorders, no wearables) — Ninacare (AI workforce platform for care homes and private hospitals)— V-Apps.cloud (QHSE+ compliance, quality and safety SaaS with patented AI automation)— QubiTale (privacy-first AI platform unlocking healthcare insights without moving or exposing confidential records)

Life-science adjacent:— Alma Serum (dairy-waste nanotech turned into high-performance skincare) — Mariscadoras / Blueat (invasive blue crab → food products, traceable chitosan, biomaterials) — AlphaFood (alternative-protein nutrition on a patented vertical insect-farming system)

Five of the ten are female-founded. 🇮🇹

Most relevant to this room: Kiran Biotech, THERA65, BrightMol Biotech, QubiTale, Nemira and Ninacare.

HOW IT WORKS

Register and tell us your thesis — stage, vertical, check size

We match against the cohort's technical profiles and send you a personal schedule with company one-pagers in advance

Dedicated 15–30 minute 1:1 matching slots, back to back, on site

Your Elpis Scale Manager contact logs follow-ups the same day and handles next steps

WHO SHOULD REGISTER

Global pharma corporate venture (CVC) and business development teams

Institutional life sciences investors and crossover funds

Kendall Square, LabCentral and MassBio ecosystem partners

Academic and clinical partners across the Longwood Medical Area

Licensing, alliance and open-innovation leads

ABOUT THE PROGRAM

The ITA Life Sciences Accelerator is an intensive 6-week program supporting a curated cohort of 10 high-growth Italian life sciences startups: 2 weeks online, 3 weeks on-site in San Diego and 1 week in Boston, connecting founders directly with US market expertise.

Delivered by Elpis Labs with the e Italian Trade Agency. Founders work through U.S. entity and IP structuring, FDA pathways, payer and hospital procurement, GTM localization and capital strategy, supported by matched Ph.D. and MBA interns from regional universities.

📩 Questions, referrals and partner slots: [email protected] or [email protected]

Capacity is limited — slots are allocated in order of confirmed thesis fit.

ABOUT ELPIS LABS

Elpis Labs is a corporate innovation and U.S. market-access firm connecting corporations, startups, investors, and public-sector organizations across global innovation ecosystems.

We help corporations discover emerging technologies, scout high-potential startups, and design pilot and innovation programs. For international startups and public-sector partners, we build accelerator, soft-landing, trade-mission, and market-entry programs that create practical pathways into the U.S. market.

🔗 elpislabs.com · New York corporate innovation & U.S. market entry · Industries we work with · Contact Elpis Labs

Ask Palaner

Going to ITA 7th Edition Life Sciences Acceleration? Ask me anything about it.

I read the organiser's pages and answer in a few seconds.

Answers are AI-generated · Privacy

Answers are AI-generated · Privacy